Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rupatadine + Fluticasone vs MP-AzeFlu in Allergic Rhinitis
NCT04601324Phase 4Withdrawn
- Sponsor
- St. Paul's Sinus Centre
- Start
- Dec 2020
- Primary completion
- Jun 2021
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of rupatadine in allergic rhinitis (AR), sponsored by St. Paul's Sinus Centre. Planned start Dec 2020; status: withdrawn.
02
Drugs
rupatadine
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT04601324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04601324.